SCHEMBL27280760

SCHEMBL27280760

NC(=O)OCc1ccc(NC=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
PRSS1 P07477 2/20 0.38
TPSAB1 Q15661 2/20 0.38
TPSD1 Q9BZJ3 1/20 0.38
TPSG1 Q9NRR2 1/20 0.38
MAPT P10636 3/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PARP10 Q53GL7 1/20 0.35
PLAU P00749 1/20 0.35
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22549263 0.83 ALDH1A1 (0.55) ALDH1A1PRSS1TPSAB1TPSD1TPSG1
SCHEMBL22990404 0.83 ALDH1A1 (0.55) ALDH1A1MAPTMEN1KMT2ACA2
SCHEMBL30437401 0.81 KMT2A (0.50) ALDH1A1MEN1KMT2ACA2NPSR1
SCHEMBL7554261 0.80 MEN1 (0.40) ALDH1A1PRSS1TPSAB1TPSD1TPSG1
SCHEMBL17621874 0.80 MAPT (0.40) ALDH1A1PRSS1TPSAB1TPSD1TPSG1
SCHEMBL19502636 0.80 ROCK2 (0.41) ALDH1A1PRSS1TPSAB1MAPTMEN1
SCHEMBL19503127 0.80 MAPT (0.41) ALDH1A1MAPTMEN1KMT2ACA1
SCHEMBL21901402 0.79 MEN1 (0.42) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL18752265 0.79 APP (0.45) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL19622209 0.79 MAPT (0.39) ALDH1A1PRSS1TPSAB1TPSD1TPSG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129614-A1 SOMATOSTATIN SUBTYPE-2 RECEPTOR (SST2R) TARGETED THERAPEUTICS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2024-06-20 WO disclosed